High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$364K
$364,141
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Bedrosian Camille L
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$94,205
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $94,205 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Bedrosian Camille L
• Officer • Chief Medical Officer
Sell to Cover
2025-12-01
$94,418
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-12-01 | $94,418 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Bedrosian Camille L
• Officer • Chief Medical Officer
Sell to Cover
2025-09-30
$175,518
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-09-30 | $175,518 | S | Form 4 |